Organisation involving high tech, life sciences and biotech
Austrianova is one organization that does services that links high tech, life sciences and biotech. It is together with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science based firm that concentrate in the enclosure of living cells or bacteria in little tablets for guarding which is also known as cell encapsulation technology, isolation, storage and transportation. We were first built in the year 2007 and was built in Singapore's top research biotech hub, Biopolis that has universal goal in offering encapsulation services like micro encapsulation.
There is a speedy increasing subject of attention in healthy repair and more exact, in the topic of neutraceuticals which is the knowing and use of probiotic bacteria. So, probiotics encapsulation was created. The cell-in-a-box technology was created by Austranova with the target to defend, cut off, collect and transfer living cells. This protective creation can be used for various reasons and can be operated to probiotics, cosmetics and agriculture environmental protection and watching as well as forming the foundation of a powerful investigation gear.
In healthcare, this skill assists facilitates harmless attaching of cells or stem cells such as cell therapy, holding them isolated from the immune system and giving long time construction of therapeutic molecules in patients. In biotechnology, the cell-in-a-box creation protects cells in bioreactors and fermentors and at the same time, it make simpler refining of bioproducts produced from the cells and it lessen manufacture price too.
A large gauge cGMP facility for the manufacturing of biomedical grade encapsulated cell tools was previously positively established and right now, Austrianova is in the process of developing this ability in the whole of SE Asia. This means the use of cell-in-a-box was quite a achievement for ancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to give lesser doses of chemotherapy to be used more productively without the common debilitating side outcomes. The encapsulated cell are situated, using supraselective catheterisation, into blood vessels that goes to the tumor where they locally switch a chemotherapeutic product to its tumor toxic product.
Visit our web for additional details: Microbeads, Cell Therapy, Pancreatic Cancer.
